Special Investigation of Kaletra in Pregnant Women
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This non-interventional, post-marketing observational study was conducted to obtain safety
data from the use of lopinavir/ritonavir (Kaletra), in clinical practice, in pregnant women
and their children in Japan.